Economical multi-site intradermal regimen with purified chick embryo cell vaccine (Rabipur) prevents rabies in people bitten by confirmed rabid animals

International Journal of Infectious Diseases

Volumn 6, Issue 3, 2002, Pages 210-214

  Madhusudana, S N ^a   Prem Anand, N ^a   Shamsundar, Ranjini ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH AND NEUROSCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

EQUINE RABIES IMMUNOGLOBULIN; IMMUNOGLOBULIN; NEUTRALIZING ANTIBODY; RABIES IMMUNOGLOBULIN; RABIES VACCINE; UNCLASSIFIED DRUG; VIRUS ANTIBODY;

ADOLESCENT; ADULT; ANIMAL TISSUE; ANTIBODY TITER; ARTICLE; CHILD; CLINICAL ARTICLE; COST EFFECTIVENESS ANALYSIS; DEVELOPING COUNTRY; DOG BITE; ERYTHEMA; FEMALE; FEVER; GROUPS BY AGE; HUMAN; IMMUNE RESPONSE; INDIA; INJECTION PAIN; INJECTION SITE; LYMPHADENOPATHY; MALE; NONHUMAN; PASSIVE IMMUNIZATION; PRURITUS; RABIES; VIRUS NEUTRALIZATION; WORLD HEALTH ORGANIZATION; ANIMAL; ANIMAL DISEASE; BITES AND STINGS; BLOOD; CHICK EMBRYO; COST BENEFIT ANALYSIS; DOG; DOG DISEASE; ECONOMICS; IMMUNIZATION; IMMUNOLOGY; INTRADERMAL DRUG ADMINISTRATION; MOUSE; SERODIAGNOSIS; VIROLOGY;

ADOLESCENT; ADULT; ANIMALS; ANTIBODIES, VIRAL; BITES AND STINGS; CHICK EMBRYO; CHILD; COST-BENEFIT ANALYSIS; DOG DISEASES; DOGS; FEMALE; HUMANS; IMMUNIZATION SCHEDULE; INDIA; INJECTIONS, INTRADERMAL; MALE; MICE; NEUTRALIZATION TESTS; RABIES; RABIES VACCINES;

EID: 0036735099     PISSN: 12019712     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1201-9712(02)90113-X     Document Type: Article

References (20)

1. Meslin F-X, Stohr K. Prospects for immunization against rabies in developing countries. India J Community Health 1996; 2:14-17.
2. John TJ. An ethical dilemma in rabies immunization. Vaccine 1997; 15(suppl):S12-S15.
3. Sehgal S. Medical and veterinary aspects of rabies control in India. India J Community Health 1996; 2:18-19.
4. Dutta JK. Rabies prevention; cost to an Indian laborer (Letter). JAMA 1996; 276:32.
5. Chutivongse S, Wilde H, Supich C, Baer GM, Fishbein DB. Post-exposure prophylaxis for rabies with antiserum and intradermal vaccination. Lancet 1990; 1:896-898.
6. World Health Organization. Supplement to the WHO expert committee recommendation on post-exposure and guidelines for the correct technique of ID immunization against rabies. WHO/EMC/ZOO 96. Geneva: WHO, 1996.
7. Warrel MJ, Warrel DA, Suntharasamai P, et al. An economical regimen of human diploid cell strain antirabies vaccine for post-exposure prophylaxis. Lancet 1983; 2:301-304.
8. Suntharasamai P, Chaiprasithikul P. Wasi C, et al. A simplified and economical intradermal regimen with purified chick embryo cell rabies vaccine for post-exposure prophylaxis. Vaccine 1994; 12:508-512.
9. Madhusudana SN, Saha SM, Sood M, Saxena SN. Multisite intradermal vaccination with tissue culture vaccine as an economical prophylactic measure against rabies. India J Med Res 1998; 87:1-4.
10. Madusudana SN, PremAnand N. Response to purified chick embryo cell vaccine administered intradermally for rabies post-exposure prophylaxis. Natl Med J India 1997; 10:115-116.
11. World Health Organization. WHO expert committee on rabies, 8th report. WHO Tech Rep Ser 1992; 824:53-55.
12. Dean DJ, Abeleseth MK, Atanasiu P. Fluorescent antibody test. In: Meslin F-X, Kaplan MM, Koprowsky H, eds. Laboratory techniques in rabies, 4th edn. Geneva: World Health Organization, 1996:86-95.
13. Koprowsky H. The mouse inoculation test. In: Meslin F-X, Kaplan MM, Koprowsky H, eds. Laboratory techniques in rabies, 4th edn. Geneva: World Health Organization, 1996:80-85.
14. Atanasiu P. Quantitative assay and potency test of antirabies serum and immunoglobulin. In: Kaplan MM, Koprowsky H, eds. Laboratory techniques in rabies, 3rd edn. Geneva: World Health Organization, 1973:314-318.
15. Hattwick MAW. Human rabies. Public Health Rev 1974; 3:229-274.
16. Turner GS. A review of world epidemiology of rabies. Trans R Soc Trop Med Hyg 1976; 70:175-178.
17. Baer GM. Control of rabies infection in animals and humans, In: Kurstak E, ed. Control of Virus diseases. New York: Marcel Decker, 1984:81-92.
18. Jaiiaroensup W, Lang P, Thipkong O, et al. Safety and efficacy of purified vero cell rabies vaccine given intramuscularly and intradermally. (Results of a prospective randomized trial.) Vaccine 1998; 16:1559-1562.
19. Centers for Disease Control. Field evaluation of pre-exposure use of human diploid cell rabies vaccine. MMWR 1983; 32:601.
20. Khawplod P, Glueck R, Wilde H, et al. Immunogenicity of purified duck embryo rabies vaccine (Lyssavac-N) with use of WHO approved intradermal post-exposure regimen. Curr Infect Dis 1995; 20:646-651.